KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Castle Biosciences (CSTL) Shares Outstanding (Weighted Average): 2018-2024

Historic Shares Outstanding (Weighted Average) for Castle Biosciences (CSTL) over the last 7 years, with Dec 2024 value amounting to $28.0 million.

  • Castle Biosciences' Shares Outstanding (Weighted Average) rose 4.58% to $29.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.0 million, marking a year-over-year increase of 4.58%. This contributed to the annual value of $28.0 million for FY2024, which is 4.08% up from last year.
  • According to the latest figures from FY2024, Castle Biosciences' Shares Outstanding (Weighted Average) is $28.0 million, which was up 4.08% from $26.9 million recorded in FY2023.
  • Over the past 5 years, Castle Biosciences' Shares Outstanding (Weighted Average) peaked at $28.0 million during FY2024, and registered a low of $19.9 million during FY2020.
  • For the 3-year period, Castle Biosciences' Shares Outstanding (Weighted Average) averaged around $27.1 million, with its median value being $26.9 million (2023).
  • Data for Castle Biosciences' Shares Outstanding (Weighted Average) shows a peak YoY rose of 27.07% (in 2021) over the last 5 years.
  • Yearly analysis of 5 years shows Castle Biosciences' Shares Outstanding (Weighted Average) stood at $19.9 million in 2020, then climbed by 27.07% to $25.3 million in 2021, then increased by 4.16% to $26.4 million in 2022, then increased by 2.12% to $26.9 million in 2023, then rose by 4.08% to $28.0 million in 2024.